The Europe Cardiovascular Ultrasound Market would witness market growth of 10% CAGR during the forecast period (2021-2027).
These cardiovascular ultrasound devices have become the important diagnostic equipment that can assist in reducing the occurrence of heart attack and stroke by offering an early diagnosis. In addition, the surge in the occurrence of heart diseases would create new growth avenues for the players operating in the cardiovascular ultrasound market during the forecasting period. Moreover, some of the major catalysts for the growth of the cardiovascular ultrasound market are surging cases of cardiovascular diseases (CVDs), increasing technological developments, and the benefits of echocardiography as compared to invasive cardiac diagnostic procedures.
European countries such as France, UK, Russia, and Germany are witnessing high demand for cardiovascular diseases, thereby fueling the demand for these systems across the region. This factor is a key trend in the regional cardiovascular ultrasound market. The regional market is majorly boosted by the supportive government initiatives and programs that promote cardiac ultrasound systems. Moreover, factors such as several technological developments associated with the cardiovascular ultrasound systems are expected to create lucrative growth opportunities for the players operating in the regional cardiovascular ultrasound market.
Moreover, the regional players are also putting heavy investments in R&D activities with an aim to bring highly advanced cardiovascular ultrasound systems into the market. The objective of these activities is to create unique, secure, and non-invasive ultrasound technologies that allow or improve interventional procedures for treating diseases, deformities, and other conditions. The increasing prevalence of different CVDs in different countries of this region would accelerate the demand for cardiovascular ultrasound in the regional market.
The Germany market dominated the Europe 2D Market by Country 2020, thereby, achieving a market value of $35.3 million by 2027. The UK market is exhibiting a CAGR of 8.3% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 9.9% during (2021 - 2027).
Based on Display, the market is segmented into Color Display and B/W Display. Based on Technology, the market is segmented into Doppler, 2D and 3D/4D. Based on Type, the market is segmented into Transthoracic echocardiography, Transesophageal echocardiography, Fetal echocardiography and Others. Based on End Use, the market is segmented into Hospital, Diagnostic centers, Ambulatory care centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cardiovascular Ultrasound Market Size will Hit $2.6 Billion by 2027, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.
By Display
By Technology
By Type
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 